Pharma BD Deal Intelligence
Ranks computed across 828 graded deals (Critic + Outcome Score both present).
Abbott acquired St. Jude Medical for $30.5B for medical devices.
FTC puts conditions on Abbott Laboratories proposed $25 billion acquisition of rival medical device maker St. Jude Medical, requiring divestitures in…
Source summaries from our enrichment pipeline; follow links for originals.
All 4 sources with sentiment breakdown →
Abbott acquired St. Jude Medical for $30.5B for medical devices.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| Abbott Laboratories / St. Jude Medical (this deal) | 2016 | $30.5B | 82 |
| Abbott Laboratories / Knoll Pharmaceutical Company (BASF Pharma) | 2001 | $6.9B | 100 |
| Abbott Laboratories / Knoll Pharmaceuticals (BASF Pharma) | 2000 | $6.9B | 95 |
| Abbott Laboratories / Alere Inc. | 2016 | $5.8B | 95 |
| Abbott Laboratories / TheraSense Inc. | 2004 | $1.2B | 81 |
| Abbott Laboratories / Vysis Inc. | 2001 | $355M | 79 |
| Abbott Laboratories / Genentech, Inc. (Roche Group) | 2007 | — | 79 |
← Browse all deals · How we score deals
More: 2016 deals · Abbott Laboratories deals · Cardiovascular deals